Format

Send to:

Choose Destination
See comment in PubMed Commons below
Onkologie. 1986 Aug;9 Suppl 1:21-3.

Epirubicin in advanced gastrointestinal (GI) cancer.

Abstract

A review of the activity of epirubicin in advanced gastrointestinal tumors is presented. In gastric cancer epirubicin has comparable activity to its parent compound doxorubicin with less toxicity. Epirubicin seems particularly active in pancreatic cancer as shown by the results of two EORTC Gastrointestinal Group studies. In advanced colorectal cancer results of different studies are conflicting and the drug may have limited activity in rectosigmoid cancer.

PMID:
3018649
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk